|
ORF cDNA clones
|
CRISPR / TALEN
|
Lentivirus
|
AAV
|
TALE-TF
|
ORF knockin clones
|
|
Antibody
|
Proteins
|
miRNA target clones
|
qPCR primers
|
shRNA clones
|
miRNA products
|
Promoter clones
|
Validated All-in-One™ qPCR Primer for SIGMAR1(NM_005866.3) Search again
By default, qPCR primer pairs are designed to measure the expression level of the splice variant (accession number) you selected for this gene WITHOUT consideration of other possible variants of this gene. If this gene has multiple variants, and you would like to measure the expression levels of one particular variant, multiple variants, or all variants, please contact us for a custom service project at inquiry@genecopoeia.com.
Validated result:
Summary
This gene encodes a receptor protein that interacts with a variety of psychotomimetic drugs, including cocaine and amphetamines. The receptor is believed to play an important role in the cellular functions of various tissues associated with the endocrine, immune, and nervous systems. As indicated by its previous name, opioid receptor sigma 1 (OPRS1), the product of this gene was erroneously thought to function as an opioid receptor; it is now thought to be a non-opioid receptor. Alternative splicing of this gene results in transcript variants encoding distinct isoforms. [provided by RefSeq].
Gene References into function
- a variant of SIGMAR1 gene is a protective factor for Alzheimer's disease
- sigma1 receptor plays a role in proliferation and adhesion of breast cancer cells
- This study establishes a central role for Sig-1R in cell survival and death.
- the present review details the evidences showing that the sigma(1) receptor is a target for neurosteroids in physiological conditions--{REVIEW}
- These results suggest that the effect of cocaine on sigma(1) receptor gene expression in the brain might be indirect and mediated through dopamine-1 receptors.
- These results suggest that HP may irreversibly inactivate sigma(1) receptors in guinea pig and human cells, probably after metabolism to reduced HP.
- No significant differences were observed for the SIGMAR1 allele, genotype, haplotype, and diplotype distributions between a group of Polish patients with late-onset AD, patients with mild cognitive impairment, and a control group.
- Developed an unambiguous assay system for measuring the affinity of ligands to the cloned human sigma(1) receptor.
- sigma-1R overexpression drives sigma agonist-independent dissociation of ANK 220 from IP3R-3, resulting in activation
